Bayern Kapital

Munich, Germany

Firm Location:Munich, Germany • Germany

Investor Firms That Co-Invest with Bayern Kapital

Novartis Venture Fund Forbion Übermorgen Ventures Brandon Capital Partners BGV (BioGeneration Ventures)Ananda Impact Ventures SOSV

Bayern Kapital Team

INVESTORS	INTRO STRENGTH	SWEET SPOT (RANGE)	INVESTMENT LOCATIONS	TOP INVESTMENT CATEGORIES
Wolfgang Dengler Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Regina Graßl Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Munich (Germany)	Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Wolfgang Härtl Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Andreas Huber Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Munich (Germany)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B) +5
Roman Huber Bayern KapitalManaging Director	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in SMB Software (Seed), Investors in BioTech (Seed), Investors in SMB Software (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +3
Nikolaj Klebert Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Munich (Germany)	Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Bernhard Koehler Bayern Kapital	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Simon Kreitmair Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Berlin (Germany)	Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Thomas Lenz Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Munich (Germany)	Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Johanna Liebner Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +11
Brigitte Linseis Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +7
Thomas Manitta Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Munich (Germany)	Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B) +4
Mathias Matusek Bayern KapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +7
Martin Redl Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +7
Georg Ried Bayern KapitalManaging Director	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +10
Franz Salzer Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Material Science (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in BioTech (Seed), Investors in Material Science (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Bernd Schafberger Bayern KapitalManaging Director	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Material Science (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in BioTech (Seed), Investors in Material Science (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Benjamin Schwiewagner Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Material Science (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in BioTech (Seed), Investors in Material Science (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Ondrej Smolek Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Material Science (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in BioTech (Seed), Investors in Material Science (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +10
Nathalie Weitemeyer Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Munich (Germany)	Investors in Material Science (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in BioTech (Seed), Investors in Material Science (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Diverse Investors (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +11
Franz Wocheslander Bayern KapitalInvestor	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Material Science (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in BioTech (Seed), Investors in Material Science (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series B), Investors in Investors who invested in diverse founders (Other Lists), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +11
Wolfgang Hanrieder Bayern Kapital	n/a	($0 - $0)